<DOC>
	<DOCNO>NCT01572142</DOCNO>
	<brief_summary>The overarch goal prospective cohort study test hypotheses great severity hyposmia associate increase risk cognitive decline PD worsen hyposmia parallel progressive cholinergic limbic denervation . To achieve goal project , patient PD without dementia at-risk dementia dementia undergo longitudinal olfactory , cognitive clinical test 2-4 year . AChE [ 11C ] PMP VAchT ( vesicular acetylcholine transporter ) [ F18 ] -FEOBV PET perform study entry 2-years ( ± 6 month ) follow-up . Brain MRI scan also perform study entry 2-years ( ± 6 month ) follow-up . Brain Beta-amyloid PET perform study entry 2 year ( ± 6 month ) . Annual olfactory test perform well understand dynamic change underlie clinical PET outcome measure .</brief_summary>
	<brief_title>Decrease Sense Smell Associated Cognitive Decline Parkinson 's Disease</brief_title>
	<detailed_description>Smell function assess use test battery odor identification , odor memory , odor discrimination test .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnosed Parkinson disease Hoehn &amp; Yahr stage 2 high , and/or duration motor disease 5 year longer 50 old disorder may resemble PD subject definite dementia subject unstable severe medical disorder subject receive neuroleptic , anticholinergic , cholinesterase inhibitor drug subject MRI image contraindicated subject receive ionizing radiation would , together current project exposure , exceed exposure limit permissible research volunteer pregnant</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Parkinson disease</keyword>
	<keyword>smell</keyword>
	<keyword>cognitive</keyword>
</DOC>